Bioeq Announces Coherus as Marketing and Distribution Partner ...
ZURICH, Nov. 7, 2019 /PRNewswire-AsiaNet/ -- - Bioeq agreement brings promise of their leading Lucentis(R) biosimilar for the treatment of retinopathies one step nearer for U.S. patients -Bioeq IP AG ("Bioeq") today announced that it signed a license and development agreement with Coheru...
Authors: LATEST ASIANET NEWS RELEASES